Home › Companies › GoodRx Holdings, Inc. › 2025-2026

GoodRx Holdings, Inc. 2025-2026 Proxy Voting Records

Compiled from SEC Form N-PX filings and GoodRx Holdings, Inc.’s Form 8-K, filed 2026-06-18 (Item 5.07 on EDGAR). Page generated 02 October 2026.

  • 5Ballot items
  • 133Asset managers
  • 492Fund votes
  • 2026-06-16Meeting date

Proxy season: 2023-2024 2024-2025 2025-2026

Explore GoodRx Holdings, Inc. in the interactive database Compare manager voting policies

Official 2025-2026 meeting results reported by GoodRx Holdings, Inc.

These tallies are GoodRx Holdings, Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2026-06-18 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

GoodRx Holdings, Inc. — official shareholder meeting results, meeting held 2026-06-16
Ballot itemForAgainst AbstainWithheldBroker non-votesOutcome
Elect Director: Wendy Barnes 2,379,952,868---- 10,078,86039,543,093 Majority: yes
Elect Director: Ronald E. Bruehlman 2,380,863,641---- 9,168,08739,543,093 Majority: yes
Elect Director: Gregory Mondre 2,382,474,121---- 7,557,60739,543,093 Majority: yes
Item 2 — Ratification of the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. 2,429,055,999335,716183,106 --0 Majority: yes
Item 3 — Approval, on an advisory (non-binding) basis, of the compensation of the Company's named executive officers. 2,363,913,37023,702,5202,415,838 --39,543,093 Majority: yes

Source: GoodRx Holdings, Inc., Form 8-K, filed with the SEC on 2026-06-18 — read the filing on EDGAR.

How asset managers voted at the GoodRx Holdings, Inc. 2025-2026 meeting

Each item below shows how the 133 asset managers that disclosed a GoodRx Holdings, Inc. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.

1. APPROVAL, ON AN ADVISORY (NON-BINDING) BASIS, OF THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS.

SECTION 14A SAY-ON-PAY VOTESMajority of the votes cast: yes

Combines 7 wordings of this item as funds reported it.

99.0% Majority: yes · of votes cast

FOR 99.0%
FOR: 2,363,913,370AGAINST: 23,702,520

GoodRx Holdings, Inc.’s own tally for this item (“Item 3 — Approval, on an advisory (non-binding) basis, of the compensation of the Company's named executive officers.”): 2,363,913,370 for, 23,702,520 against, per its Form 8-K filed 2026-06-18 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Share-of-outstanding not shown: votes cast exceed the reported share count, which usually means multiple share classes with different voting rights.

The 132 asset managers below cast 92% of the shares they voted on this item FOR (200,362,111 for, 18,002,129 against).

FOR 91%8%
FOR: 200,362,111 (90.8%)AGAINST: 18,002,129 (8.2%)ABSTAIN: 2,181,743 (1.0%)
Largest asset managers voting on “APPROVAL, ON AN ADVISORY (NON-BINDING) BASIS, OF THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS.” at GoodRx Holdings, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Silver Lake Group, L.L.C.129,527,6080 00For
Francisco Partners Management, LP60,078,1840 00For
Vanguard4,862,4953,392,310 130For
Petrus Trust Company, LTA3,098,5590 00For
PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C.00 2,105,5020Abstain
LSV ASSET MANAGEMENT02,088,134 00Against
Technology Crossover Management X, Ltd.1,653,5660 00For
AMERIPRISE FINANCIAL INC01,439,024 00Against
BlackRock16,1481,261,867 00Against
Charles Schwab01,125,374 00Against
Invesco01,081,508 00Against
AQR0952,893 00Against
SEI0793,364 00Against
STIFEL NICOLAUS & CO INC \MO\0792,486 00Against
Pacer Funds Trust0742,362 00Against
Goldman Sachs484,6880 00For
Northern Trust0440,988 00Against
Universal-Investment-Gesellschaft mbH0379,634 00Against
Victory Capital0350,820 00Against
MACKENZIE FINANCIAL CORP0348,989 00Against
MOORE CAPITAL MANAGEMENT, LP0300,838 00Against
UI BVK Kapitalverwaltungsgesellschaft mbH0286,300 00Against
Dimensional0227,223 00Against
Janney Montgomery Scott LLC0203,088 00Against
Evercore Wealth Management, LLC0184,834 00Against

Showing the 25 largest of 132 asset managers. See all 132 in the interactive database.

2. Election of Directors: Gregory Mondre

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

99.6% Majority: yes · of votes cast

FOR 99.6%
FOR: 2,382,474,121WITHHELD: 7,557,607

GoodRx Holdings, Inc.’s own tally for this item (“Elect Director: Gregory Mondre”): 2,382,474,121 for, 7,557,607 withheld, per its Form 8-K filed 2026-06-18 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Share-of-outstanding not shown: votes cast exceed the reported share count, which usually means multiple share classes with different voting rights.

The 25 asset managers below cast 100% of the shares they voted on this item FOR (9,799,803 for, 0 against).

FOR 93%7%
FOR: 9,799,803 (93.0%)ABSTAIN: 741,095 (7.0%)
Largest asset managers voting on “Election of Directors: Gregory Mondre” at GoodRx Holdings, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard7,556,3260 8,7850For
Pacer Funds Trust742,3620 00For
Charles Schwab562,0750 00For
SEI396,3000 00For
Invesco288,6580 00For
Northern Trust00 256,8920Abstain
WisdomTree00 172,6950Abstain
Dimensional00 143,6680Abstain
Fidelity102,0940 41,2720For
Harbor ETF Trust70,4030 00For
Legg Mason38,1140 00For
BlackRock00 37,8350Abstain
American Century00 29,1690Abstain
Russell Investments27,4010 00For
State Street250 23,0950Abstain
Goldman Sachs16,0450 00For
Prudential/PGIM00 12,4700Abstain
Lincoln Financial00 8,9590Abstain
Allianz00 3,0970Abstain
John Hancock00 2,0900Abstain
Advisors' Inner Circle Fund III00 5010Abstain
Blackstone Alternative Investment Funds00 3000Abstain
Victory Capital00 1030Abstain
Jackson National00 840Abstain
E Trade Trust00 800Abstain

3. Election of Directors: Ronald E. Bruehlman

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

99.6% Majority: yes · of votes cast

FOR 99.6%
FOR: 2,380,863,641WITHHELD: 9,168,087

GoodRx Holdings, Inc.’s own tally for this item (“Elect Director: Ronald E. Bruehlman”): 2,380,863,641 for, 9,168,087 withheld, per its Form 8-K filed 2026-06-18 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Share-of-outstanding not shown: votes cast exceed the reported share count, which usually means multiple share classes with different voting rights.

The 25 asset managers below cast 100% of the shares they voted on this item FOR (10,168,136 for, 0 against).

FOR 96%
FOR: 10,168,136 (96.5%)ABSTAIN: 372,762 (3.5%)
Largest asset managers voting on “Election of Directors: Ronald E. Bruehlman” at GoodRx Holdings, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard7,565,0850 260For
Pacer Funds Trust742,3620 00For
Charles Schwab562,0750 00For
SEI396,3000 00For
Invesco288,6580 00For
Northern Trust256,8920 00For
WisdomTree00 172,6950Abstain
Dimensional00 143,6680Abstain
Fidelity143,3660 00For
Harbor ETF Trust70,4030 00For
Legg Mason38,1140 00For
BlackRock37,8350 00For
American Century00 29,1690Abstain
Russell Investments27,4010 00For
State Street23,0990 210For
Goldman Sachs16,0450 00For
Prudential/PGIM00 12,4700Abstain
Lincoln Financial00 8,9590Abstain
Allianz00 3,0970Abstain
John Hancock00 2,0900Abstain
Advisors' Inner Circle Fund III5010 00For
Blackstone Alternative Investment Funds00 3000Abstain
Victory Capital00 1030Abstain
Jackson National00 840Abstain
E Trade Trust00 800Abstain

4. Election of Directors: Wendy Barnes

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

99.5% Majority: yes · of votes cast

FOR 99.5%
FOR: 2,379,952,868WITHHELD: 10,078,860

GoodRx Holdings, Inc.’s own tally for this item (“Elect Director: Wendy Barnes”): 2,379,952,868 for, 10,078,860 withheld, per its Form 8-K filed 2026-06-18 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Share-of-outstanding not shown: votes cast exceed the reported share count, which usually means multiple share classes with different voting rights.

The 25 asset managers below cast 100% of the shares they voted on this item FOR (9,879,477 for, 0 against).

FOR 94%
FOR: 9,879,477 (93.7%)ABSTAIN: 661,421 (6.3%)
Largest asset managers voting on “Election of Directors: Wendy Barnes” at GoodRx Holdings, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard7,565,0840 270For
Pacer Funds Trust742,3620 00For
Charles Schwab562,0750 00For
SEI396,3000 00For
Invesco00 288,6580Abstain
Northern Trust256,8920 00For
WisdomTree00 172,6950Abstain
Dimensional00 143,6680Abstain
Fidelity143,3660 00For
Harbor ETF Trust70,4030 00For
Legg Mason38,1140 00For
BlackRock37,8350 00For
American Century00 29,1690Abstain
Russell Investments27,4010 00For
State Street23,0990 210For
Goldman Sachs16,0450 00For
Prudential/PGIM00 12,4700Abstain
Lincoln Financial00 8,9590Abstain
Allianz00 3,0970Abstain
John Hancock00 2,0900Abstain
Advisors' Inner Circle Fund III5010 00For
Blackstone Alternative Investment Funds00 3000Abstain
Victory Capital00 1030Abstain
Jackson National00 840Abstain
E Trade Trust00 800Abstain

5. RATIFICATION OF THE APPOINTMENT OF KPMG LLP AS THE COMPANY'S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2026.

AUDIT-RELATEDMajority of the votes cast: yes

99.9% Majority: yes · of votes cast

FOR 99.9%
FOR: 2,429,055,999AGAINST: 335,716

GoodRx Holdings, Inc.’s own tally for this item (“Item 2 — Ratification of the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026.”): 2,429,055,999 for, 335,716 against, per its Form 8-K filed 2026-06-18 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Share-of-outstanding not shown: votes cast exceed the reported share count, which usually means multiple share classes with different voting rights.

The 25 asset managers below cast 100% of the shares they voted on this item FOR (10,540,897 for, 0 against).

FOR 100%
FOR: 10,540,897 (100.0%)
Largest asset managers voting on “RATIFICATION OF THE APPOINTMENT OF KPMG LLP AS THE COMPANY'S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR” at GoodRx Holdings, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard7,565,1100 00For
Pacer Funds Trust742,3620 00For
Charles Schwab562,0750 00For
SEI396,3000 00For
Invesco288,6580 00For
Northern Trust256,8920 00For
WisdomTree172,6950 00For
Dimensional143,6680 00For
Fidelity143,3660 00For
Harbor ETF Trust70,4030 00For
Legg Mason38,1140 00For
BlackRock37,8350 00For
American Century29,1690 00For
Russell Investments27,4010 00For
State Street23,1200 00For
Goldman Sachs16,0450 00For
Prudential/PGIM12,4700 00For
Lincoln Financial8,9590 00For
Allianz3,0970 00For
John Hancock2,0900 00For
Advisors' Inner Circle Fund III5010 00For
Blackstone Alternative Investment Funds3000 00For
Victory Capital1030 00For
Jackson National840 00For
E Trade Trust800 00For

Largest GoodRx Holdings, Inc. shareholders voting in 2025-2026

Ranked by the number of GoodRx Holdings, Inc. shares each manager voted on the most widely held ballot item of the 2025-2026 meeting, shown as a share of the 340,531,000 shares outstanding at the time of that meeting.

Top GoodRx Holdings, Inc. shareholders by shares voted, 2025-2026
#Asset manager % of shares outstanding
1Silver Lake Group, L.L.C. 38.04%
2Francisco Partners Management, LP 17.64%
3Vanguard 2.42%
4Petrus Trust Company, LTA 0.91%
5PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. 0.62%
6LSV ASSET MANAGEMENT 0.61%
7Technology Crossover Management X, Ltd. 0.49%
8AMERIPRISE FINANCIAL INC 0.42%
9BlackRock 0.38%
10Charles Schwab 0.33%

Reported GoodRx Holdings, Inc. ownership

Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).

GoodRx Holdings, Inc. beneficial owners on record for the 2025-2026 proxy season
Holder % outstanding Disclosure
Francisco Partners GP IV, L.P. 15.44% 13D
Vanguard Group 2.81% 13F
Renaissance Technologies 0.96% 13F
Dimensional Fund Advisors 0.72% 13F
BlackRock 0.55% 13F
AQR Capital 0.53% 13F
Morgan Stanley 0.33% 13F
Geode Capital 0.32% 13F
Goldman Sachs 0.31% 13F
State Street 0.30% 13F

Percentages above are of 340,531,000 shares outstanding, as reported by GoodRx Holdings, Inc. on its Form 10-Q dated 2026-03-31 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from GoodRx Holdings, Inc.’s 10-Q dated 2026-03-31. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.

At GoodRx Holdings, Inc.'s shareholder meeting held 2026-06-16, in the 2025-2026 proxy season, 133 asset managers reported how they voted on 5 ballot items in their SEC Form N-PX filings, covering 492 separate fund positions. On the most widely held item on that ballot — APPROVAL, ON AN ADVISORY (NON-BINDING) BASIS, OF THE COMPENSATION OF THE COMPANY'S NAMED… — FOR was 99.0% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: GoodRx Holdings, Inc.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2026-06-18.

GoodRx Holdings, Inc. proxy season coverage: 2023-2024 · 2024-2025 · 2025-2026 (this page).